503 related articles for article (PubMed ID: 26779634)
1. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
[TBL] [Abstract][Full Text] [Related]
2. The Role of DNA Repair (
Crișan AS; Tripon F; Bogliș A; Crauciuc GA; Trifa AP; Lázár E; Macarie I; Gabor MR; Bănescu C
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541232
[No Abstract] [Full Text] [Related]
3. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
5. Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population.
Nigam K; Yadav SK; Samadi FM; Bhatt ML; Gupta S; Sanyal S
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2397-2403. PubMed ID: 31450912
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
[TBL] [Abstract][Full Text] [Related]
8. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients.
Le Morvan V; Longy M; Bonaïti-Pellié C; Bui B; Houédé N; Coindre JM; Robert J; Pourquier P
Int J Cancer; 2006 Oct; 119(7):1732-5. PubMed ID: 16646069
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
[TBL] [Abstract][Full Text] [Related]
12. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
15. Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome.
Ravegnini G; Nannini M; Simeon V; Musti M; Sammarini G; Saponara M; Gatto L; Urbini M; Astolfi A; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
Tumour Biol; 2016 Oct; 37(10):13413-13423. PubMed ID: 27460091
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine.
Mlak R; Krawczyk P; Homa-Mlak I; Powrózek T; Ciesielka M; Kozioł P; Milanowski J; Małecka-Massalska T
Pathol Oncol Res; 2019 Jul; 25(3):1035-1045. PubMed ID: 30066234
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
Ding DP; He XF; Zhang Y
Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
[TBL] [Abstract][Full Text] [Related]
19. Modulation of DNA damage by XPF, XPG and ERCC1 gene polymorphisms in pesticide-exposed agricultural workers of Punjab, North-West India.
Kaur K; Kaur R
Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503302. PubMed ID: 33551103
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]